NEW REPORT – The Threat of AMR to Japan’s Super-Aging Society: Implications on Health Care, Public Policy, and Economic Well-Being

New York and Tokyo (February 21, 2021) – Today, the Global Coalition on Aging (GCOA) and the Health and Global Policy Institute (HGPI) announced a report sharing key policy-focused takeaways from their roundtable on antimicrobial resistance (AMR) in super-aging Japan. On October 7, 2020, the roundtable convened experts from across the business, government, academic, aging, and non-profit sectors in a policy discussion that recognized the multifaceted risks of AMR in aging societies around the world, including super-aging Japan. In particular, Japan and other societies have the opportunity to apply lessons from the global COVID-19 response to the AMR challenge. The roundtable was held by GCOA in collaboration with HGPI and sponsored by Pfizer Japan.

Five key takeaways from the roundtable focused on spurring urgent action in the fight against AMR to support of healthy aging and a robust silver economy in super-aging Japan:

  1. AMR is an urgent public health issue, especially for Japan’s super-ageing population. Policy support and decisive actions focused on this vulnerable population are needed.
  2. The dearth of new antimicrobials represents a major market failure that requires new incentives and market-based policy reform.
  3. Empowerment of the ageing population has become increasingly critical in the shadows of COVID-19.
  4. A broad-based, society-wide set of multi-stakeholder interests are needed to address AMR issues.
  5. As the world’s first super-ageing country, Japan is expected to take a leading role on AMR internationally.

Click here to read the report in English. Click here to read the report in Japanese.

Michael W. Hodin, CEO of GCOA, and Dr. Hiroyuki Noda, Councilor at Office for Pandemic Influenza and New Infectious Diseases & Coordination Office of Measures on Emerging Infectious Disease, Cabinet Secretariat, gave opening remarks. Key comments included:

“The Japanese government plays a key role in partnering with businesses to address the growing AMR challenge in our country and around the world. Right now, we need communication and collaboration across sectors. A multi-sectoral approach is the only way to address a challenge of this magnitude,” said Dr. Hajime Inoue, Deputy Director General of the Office for Novel Coronavirus Disease Control, Cabinet Secretariat.

Dr. Norio Ohmagari, Director of the AMR Clinical Reference Center and Director of the Disease Control and Prevention Center of the National of Center for Global Health and Medicine (NCGM) addressed Japan’s unique position as a super-aging society: “The use of injectable antimicrobials for patients over 65 years of age is increasing every year in Japan. As Japan tackles AMR, other aging populations will look to us—the world’s first aging society—for leadership on addressing the AMR challenge in the context of population aging.”

Emphasizing the importance of innovation, Michael W. Hodin said, “Because of Japan’s super-aging status, AMR poses a unique and heightened threat to the country. Despite this urgency, antibiotic innovation has all but dried up. In order to fully support its aging population, Japan must commit to supporting an innovation-friendly environment that incentivizes investment in new antibiotics and fosters a robust pipeline of antibiotics.”

AMR is a principal barrier to healthy aging and threatens lifesaving 20th-century progress in science, medicine, and sanitation in societies around the world, including in super-aging Japan. To read GCOA’s Call to Action to tackle AMR, click here.

 

Global Coalition on Aging

The Global Coalition on Aging aims to reshape how global leaders approach and prepare for the 21st century’s profound shift in population aging. GCOA uniquely brings together global corporations across industry sectors with common strategic interests in aging populations, a comprehensive and systemic understanding of aging, and an optimistic view of its impact. Through research, public policy analysis, advocacy, and strategic communications, GCOA is advancing innovative solutions and working to ensure global aging is a path to health, productivity and economic growth.

 

Health and Global Policy Institute (HGPI)

Health and Global Policy Institute (HGPI) is a Tokyo-based, independent, non-profit, and non-partisan health policy think tank established in 2004. Since its establishment, HGPI has been working to realize citizen-centric health policies by gathering together diverse stakeholders and developing policy recommendations. HGPI is committed to serving as a truly independent organization that can provide society with new ideas from a broad, long-term perspective in order to foster fair and healthy communities. HGPI looks forward to continuing to partner with people from all around the world as we continue our work for the development of effective health policy solutions for Japanese and global issues.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

What Old Age Might Be Like for Today’s 30-Year-Olds

Get ready for a new old age. With the U.S. fertility rate in a decadelong slump and the life expectancy of 65-year-old Americans approaching roughly 85, our aging nation is likely to grow older by midcentury, as the ratio of young to old continues to decline. The trend is likely to upend how our society is organized, making life very different for today’s 30-year-olds when they reach their 60s compared with life for 60-year-olds now.

World Population Reaches 8bn As It Grows Older

The world’s population reached 8bn people on Tuesday and will hit 9bn in 15 years as it experiences an unprecedented surge in the number of older people, according to the latest UN data. The global fertility rate has more than halved since the 1950s to 2.3 births per woman. With mortality also falling, the number of people aged 65 and over is expected to rise from 783mn in 2022 to 1bn by 2030 and reach 1.4bn by 2043, the UN population data revealed.

Global Coalition on Aging (GCOA) Launches Cross-Sector Alliance Committed to Health Innovation at High-Level Forum on The Silver Economy

Today, the Global Coalition on Aging (GCOA), along with cross-sector stakeholders representing patient advocacy, policy, industry, and academic communities, announced the launch of the Alliance for Health Innovation at the High-Level Forum on the Silver Economy in New York. The Alliance is dedicated to establishing the importance of innovation in achieving healthy aging and health equity through investments, policy reforms, and strategic partnerships.

Japan Must Face Up to Growing Danger of Drug-resistant Germs

In the wake of more than 6.4 million COVID-19 deaths worldwide and unprecedented economic destruction, the global community has no excuse to be caught unprepared for the next pandemic. Yet right now, a devastating parallel plague is already underway and worsening. Some years, it is killing well over 1 million people, according to medical journal The Lancet.

A Bipartisan Bill Could Prevent The Next Pandemic

In Washington, Republicans and Democrats are typically at loggerheads when it comes to healthcare policy. Just consider the recent Inflation Reduction Act, which made extensive changes to Medicare and also extended Affordable Care Act subsidies. Every single congressional Democrat voted for the legislation, while every single member of the GOP voted against it. But occasionally, a bill is such an obviously good idea, and so desperately needed, that it commands significant bipartisan support. The PASTEUR Act, co-sponsored by 31 Democrats and 31 Republicans in the House and two members of each party in the Senate, is just such a bill.

Korea Must Act Now to Combat Growing AMR Threat

Public officials are overlooking one of the gravest long-term threats to the Korean people, the health system, and economy: antimicrobial resistance (AMR). Some pathogens ― bacteria, fungi, parasites, and viruses ― have evolved strains that resist the antimicrobial medications we currently have available to fight them. Health care professionals often must watch helplessly as patients succumb to infections that antibiotics could once have easily beaten. They know that new antimicrobials, including and especially antibiotics, could easily gain the victory ― but they have none at their disposal.

Policy Statement on the Impact of Price Negotiations on Innovation, Healthy Aging and Equity

As the CEO of the Global Coalition on Aging (GCOA) and a newly formed cross-sector Alliance for Health Innovation, we write to express our deep concern with the current legislation that allows for price “negotiations” in Medicare – a thinly veiled signal for America’s plunge into price controls that will have a devastating and adverse impact on biopharmaceutical innovation and our nations’ ability to support healthy aging.